Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03098160
Title Immunotherapy Study of Evofosfamide in Combination With Ipilimumab
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Threshold Pharmaceuticals
Indications

head and neck squamous cell carcinoma

prostate cancer

melanoma

pancreatic cancer

Therapies

Evofosfamide + Ipilimumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.